β1-adrenergic receptor activation enhances memory in Alzheimer's disease model

Commentary to the recently published review “Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease” by Li, Evrahimi and Schluesener. Ageing Res. Rev. 2013 Jan;12(1):116–40

(2013) M. Windisch et al.   AGEING RESEARCH REVIEWS

Social memory, amnesia, and autism: Brain oxytocin secretion is regulated by NAD+ metabolites and single nucleotide polymorphisms of CD38

(2012) Haruhiro Higashida et al.   NEUROCHEMISTRY INTERNATIONAL

Tau-Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer's and Pick's Disease

(2012) Yazi Ke et al.   PLoS One

Thy1-hAPPLond/Swe+mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function

(2012) Mehrdad Faizi et al.   Brain and Behavior

Aberrant phosphorylation in the pathogenesis of Alzheimer's disease

(2011) Sul-Hee Chung   BMB Reports

Upregulation of CREB-Mediated Transcription Enhances Both Short- and Long-Term Memory

(2011) A. Suzuki et al.   JOURNAL OF NEUROSCIENCE

Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down Syndrome: Activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer

(2011) Mehrdad Faizi et al.   NEUROBIOLOGY OF DISEASE

Hypothalamic Vasopressin and Oxytocin mRNA Expression in Relation to Depressive State in Alzheimer’s Disease: A Difference With Major Depressive Disorder

(2009) G. Meynen et al.   JOURNAL OF NEUROENDOCRINOLOGY

Housing conditions and stimulus females: a robust social discrimination task for studying male rodent social recognition

(2009) Abbe H Macbeth et al.   Nature Protocols

Neural correlates of scent marking behavior in C57BL/6J mice: detection and recognition of a social stimulus

(2009) K.G. Borelli et al.   NEUROSCIENCE

Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome

(2009) A. Salehi et al.   Science Translational Medicine